Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Items Equity Method and Non-marketable Equity Investments (Details)

v3.19.2
Composition of Certain Financial Statement Items Equity Method and Non-marketable Equity Investments (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Jun. 30, 2019
Sep. 30, 2018
Equity Method and Non-marketable Equity Investments [Line Items]      
Equity method investments   $ 330 $ 402
Non-marketable equity investments   800 650
Carrying value of equity method and non-marketable equity investments   $ 1,130 $ 1,052
Equity Method Investee [Member]      
Equity Method and Non-marketable Equity Investments [Line Items]      
Non-cash consideration received from equity method investee $ 98    
Other Restructuring [Member]      
Equity Method and Non-marketable Equity Investments [Line Items]      
Non-cash consideration received for divestiture $ 53